Sonoma Pharmaceuticals (SNOA) PT Lowered to $7 at Maxim Group
Tweet Send to a Friend
Maxim Group lowered its price target on Sonoma Pharmaceuticals (NASDAQ: SNOA) to $7.00 (from $11.00) while maintaining a Buy rating.Analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
